Statistical Classification Strategy for Proton Magnetic Resonance Spectra of Soft Tissue Sarcoma: An Exploratory Study with Potential Clinical Utility

Purpose: Histological grading is currently one of the best predictors of tumor behavior and outcome in soft tissue sarcoma. However, occasionally there is significant disagreement even among expert pathologists. An alternative method that gives more reliable and non-subjective diagnostic information is needed. The potential use of proton magnetic resonance spectroscopy in combination with an appropriate statistical classification strategy was tested here in differentiating normal mesenchymal tissue from soft tissue sarcoma. Methods: Fifty-four normal and soft tissue sarcoma specimens of various histological types were obtained from 15 patients. One-dimensional proton magnetic resonance spectra were acquired at 360 MHz. Spectral data were analyzed by using both the conventional peak area ratios and a specific statistical classification strategy. Results: The statistical classification strategy gave much better results than the conventional analysis. The overall classification accuracy (based on the histopathology of the MRS specimens) in differentiating normal mesenchymal from soft tissue sarcoma was 93%, with a sensitivity of 100% and specificity of 88%.The results in the test set were 83, 92 and 76%, respectively. Our optimal region selection algorithm identified six spectral regions with discriminating potential, including those assigned to choline, creatine, glutamine, glutamic acid and lipid. Conclusion: Proton magnetic resonance spectroscopy combined with a statistical classification strategy gave good results in differentiating normal mesenchymal tissue from soft tissue sarcoma specimens ex vivo. Such an approach may also differentiate benign tumors from malignant ones and this will be explored in future studies.

[1]  J. Saunders,et al.  A simple procedure for obtaining high‐quality nmr spectra of semiquantitative value from small tissue specimens: cervical biopsies. , 1992, Magnetic resonance in medicine.

[2]  L. Seeger,et al.  The role of plain radiography, computed tomography, and magnetic resonance imaging in sarcoma evaluation. , 1995, Hematology/oncology clinics of North America.

[3]  S. Singer,et al.  New diagnostic modalities in soft tissue sarcoma. , 1999, Seminars in surgical oncology.

[4]  R L Somorjai,et al.  Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.

[5]  A. Okada,et al.  Increased aspartate and glutamate levels in both gastric and colon cancer tissues. , 1993, The Tokushima journal of experimental medicine.

[6]  D. Cory,et al.  Gradient, high‐resolution, magic‐angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue , 1997, Magnetic resonance in medicine.

[7]  M. Dewhirst,et al.  MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. , 1994, Radiology.

[8]  P. Bottomley Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[9]  R. Dahiya,et al.  Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  Peter Russell,et al.  Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.

[11]  C. Mountford,et al.  Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology , 1993, Magnetic resonance in medicine.

[12]  J. S. Cohen,et al.  Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. , 1987, The Journal of biological chemistry.

[13]  M. Sivaraja,et al.  1H-NMR detectable fatty acyl chain unsaturation in excised leiomyosarcoma correlate with grade and mitotic activity. , 1996, The Journal of clinical investigation.

[14]  T. Alvegård,et al.  Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  T. Brown,et al.  Methodological standardization for a multi‐institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies , 2004, NMR in biomedicine.

[16]  R L Somorjai,et al.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.

[17]  R. Somorjai,et al.  Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. , 1996, Anticancer research.

[18]  O. Jardetzky,et al.  Characterization of lipid composition in stimulated human lymphocytes by 1H-NMR. , 1990, Biochimica et biophysica acta.

[19]  W. Negendank MR spectroscopy of musculoskeletal soft-tissue tumors. , 1995, Magnetic resonance imaging clinics of North America.

[20]  Prognostic factors in soft tissue sarcoma. , 1999, Seminars in surgical oncology.

[21]  T. Eberlein,et al.  Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue Sarcoma , 1994, Annals of surgery.

[22]  Negendank Wg MR spectroscopy of musculoskeletal soft-tissue tumors. , 1995 .

[23]  J. Coindre,et al.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma , 1986, Cancer.

[24]  R L Somorjai,et al.  Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.

[25]  M. Heslin,et al.  Imaging of soft tissue sarcomas. , 1999, Surgical oncology clinics of North America.

[26]  W. Mackinnon,et al.  Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.

[27]  R. Somorjai,et al.  Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.

[28]  R. Pollock,et al.  Soft Tissue Sarcomas , 2001, CA: a cancer journal for clinicians.

[29]  B Sundell,et al.  Soft-tissue sarcomas. , 1979, British medical journal.

[30]  R. Lenkinski,et al.  Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors , 1991, Cancer.

[31]  M. Crowley,et al.  Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy. , 1989, Radiology.

[32]  E. Jackson,et al.  Soft-tissue sarcoma of the extremities. MR appearance of post-treatment changes and local recurrences. , 1995, Magnetic Resonance Imaging Clinics of North America.

[33]  B. Fletcher,et al.  MR imaging of malignant soft-tissue tumors. , 1995, Magnetic resonance imaging clinics of North America.

[34]  Hanna Sl,et al.  MR imaging of malignant soft-tissue tumors. , 1995 .